A$ 0.91
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is neutral on EV/EBITDA, underpriced on P/FC.
Target Price
The average target price of HLS.AX is 0.84 and suggests 0% downside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati
